Health-care companies were more or less flat as traders rotated into laggards from the volatile technology sector.
Health-care companies were more or less flat as traders rotated into laggards from the volatile technology sector.
Eli Lilly agreed to buy neuroscience firm 4E Therapeutics, in what analysts said was the drug maker's latest attempt to develop a painkiller.
Amphastar Pharmaceuticals got approval from the Food and Drug Administration for an over-the-counter nasal spray to treat opioid overdose.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
Health-care companies fell as traders continued to rotate out of a sector beset by growth and regulatory concerns.
Health-care companies rose as traders continued to rotate out of high-momentum semiconductor and artificial-intelligence stocks…
Health-care companies rose as traders rotated into defensive sectors due to volatility in oil and Treasury markets.
Health-care companies fell, but not by much, as traders continued rotating out of tech into lagging sectors.
Health-care companies ticked down as traders rotated back into the technology sector.
Health-care companies rose sharply in an abrupt sector rotation.
